Golden Throat continued to be listed on the main board of Hong Kong and developed steadily

At 10:00 a.m. on November 30, Golden Throat Holdings Group Limited officially held a court meeting and an extraordinary general meeting of shareholders in Hong Kong. Affected by the epidemic, the meeting was held online.

Under the principle of openness and fairness, the voting work was finally successfully completed. According to the scrutineers, the privatization resolution contained in the circular could not be adopted at the meeting. Based on this, the privatization agreement will not be implemented and the listing status of the Main Board of Golden Throat Hong Kong will remain unchanged (stock code: 6896. HK)。

The company said that it would like to thank all shareholders and all walks of life for their attention and support to Golden Throat all the way, respect the decisions of all shareholders, and sincerely thank all parties for their participation and cooperation. The company's revenue in the first half of 2021 increased by 83.1% over the same period last year, in 2005 Golden Throat Throat Treasure was recognized as a well-known trademark in China; in 2010, In the "China 500 Most Valuable Brands Ranking", Golden Throat ranked 263rd; in November 2017, Golden Throat won the honor of "World Famous Brand", in the same year, the company was awarded the Forbes List of Potential Enterprises of Chinese Listed Companies; in 2018, Golden Throat continued to win the "Top 500 Most Valuable Brands in China". The brand value is 7.15 billion yuan; in 2019, it ranked 430th in the "China's 500 Most Valuable Brands List", with a brand value of 8.26 billion yuan.

In the 2021 comprehensive statistical ranking of China's over-the-counter drug enterprises and product brands, Golden Throat Group ranked 43rd among China's non-prescription drug companies, and Golden Throat Tablets won the first place in "Proprietary Chinese Medicine • Throat Category" for many consecutive years. It fully shows the recognition and affirmation of the brand of Golden Throat in the domestic and foreign markets. And exported to the United States, Canada, the European Union, Russia, Australia and Southeast Asia and other more than 50 countries and regions.

Golden Throat has been committed to brand building, and the brand value has been continuously improved. In recent years, in order to promote the company's brand replacement and upgrading, to achieve the development of the old brand, Golden Throat has taken the initiative to step out of the comfort zone and continue to rejuvenate its vitality through product innovation and capacity upgrading. In the future, Golden Throat will continue to actively practice the development plan of "one nuclear and three poles" of great health and enhance the core competitiveness of the Group. Whether it is in the international brand influence, innovative R & D and production level, marketing strength are more attentive to operate. The company will also strive to make biotechnology and health a leader in the health industry in China and the world.